-
Certara will host two Phoenix WinNonlin™ Lunch and Learns and also lead 18 workshop, presentation and poster sessions on model-informed drug development
Nov 3, 2019
-
Oct 28, 2019
-
Today, Thermo Fisher Scientific announced a co-marketing agreement with Genialis, a data science company leading the industry in RNA-based discovery, that aims to streamline data analysis for high-throughput genome sequencing. Together, these companies ae addressing one of the most problematic bottlenecks in the next-generation sequencing workflow – Informatics.
The agreement will create an analysis workflow integrating the Invitrogen Collibri Stranded RNA Library Prep Kit for Illumina Systems with Genialis Expressions analysis software to support the data analysis needs of Thermo Fisher Collibri customers, effectively shortening the time from raw data to discovery.
Oct 28, 2019
-
Sep 30, 2019
-
In her new position, Ms. Ball will be responsible for providing leadership and strategic direction on operational and business decisions, including growth planning, business and organizational development, risk management, and quality control.
Oct 1, 2019
-
The Simcyp Consortium was created as a collaborative research center to develop best practices and progress physiologically-based pharmacokinetic (PBPK) modeling and simulation, the science of studying drug handling by the body in computer-generated, virtual patients. Today, it counts 37 leading biopharmaceutical companies among its members and is a global authority on mechanistic PBPK modeling and simulation. Consortium members work together in a pre-competitive environment to progress model-informed drug development and create annual updates to Certara’s Simcyp Population-based Simulator.
Oct 15, 2019
-
BioIVT, a leading provider of research models and services for drug and diagnostic development, has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN. This acquisition will significantly expand BioIVT’s immunology and disease-state product portfolios, enhancing its ability to support immuno-oncology and cell therapy researchers.
Oct 15, 2019
-
A team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) in Ireland will be using Shimmer’s Verisense™ continuous monitoring platform to study fatigue accurately in individuals with breast cancer, enabling the development of better predictive models and interventions.
Oct 9, 2019
-
3DR Laboratories provides hospitals, imaging centers, and radiology practices with consistent, high quality, 3D post-processed MRI and CT images
Oct 21, 2019
-
Certara’s BaseCase platform can now perform live statistical modeling and sophisticated data analyses, enabling pharmaceutical and medtech clients to deliver evidence-based claims to support value messages during discussions with payers, providers and healthcare professionals.
Sep 30, 2019
-
Cadex Genomics Builds Out Leadership Team with Election of Kathy Hibbs to Board as an Independent Director. Hibbs brings more than 25 years of legal and management expertise in clinical diagnostic market segment to Cadex Genomics
Oct 17, 2019
-
Sessions feature physiologically-based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD) and quantitative systems pharmacology (QSP) modeling and simulation
Oct 17, 2019
-
MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM ‘19, (European Association of Nuclear Medicine) last week in Barcelona. The range comprising four models, including a small benchtop PET/CT, can accommodate small animals up to 12 kg.
Oct 23, 2019
-
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
Sep 25, 2019
-
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
Sep 24, 2019
-
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
Sep 24, 2019
-
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
Sep 17, 2019
-
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
Sep 17, 2019
-
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
Sep 17, 2019
-
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
Sep 12, 2019